CA Stock MarketDetailed Quotes
BRM Biorem Inc
- 2.060
- +0.010+0.49%
15min DelayMarket Closed Jul 5 16:00 ET
32.34MMarket Cap11.14P/E (TTM)
2.100High2.010Low38.60KVolume2.060Open2.050Pre Close80.09KTurnover2.28052wk High0.25%Turnover Ratio15.70MShares0.81052wk Low0.185EPS TTM31.69MFloat Cap3.790Historical High15.85P/E (Static)15.39MShs Float0.080Historical Low0.13EPS LYR4.39%Amplitude--Dividend TTM4.38P/B1Lot Size--Div YieldTTM
Biorem Inc Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 86.73%5.92M | -12.81%25.17M | 11.88%12.21M | -24.61%5.51M | -31.67%4.28M | -27.65%3.17M | 17.91%28.86M | 0.66%10.91M | 59.69%7.31M | 11.18%6.26M |
| Operating revenue | 86.73%5.92M | -12.81%25.17M | 11.88%12.21M | -24.61%5.51M | -31.67%4.28M | -27.65%3.17M | 17.91%28.86M | 0.66%10.91M | 59.69%7.31M | 11.18%6.26M |
| Cost of revenue | 35.57%4.14M | -9.74%18.14M | 11.39%7.8M | -17.22%3.97M | -30.81%3.33M | -12.84%3.05M | 10.20%20.1M | -1.84%7M | 39.26%4.79M | 6.41%4.81M |
| Gross profit | 1,421.32%1.78M | -19.86%7.02M | 12.75%4.41M | -38.66%1.54M | -34.53%953.57K | -86.69%116.99K | 40.49%8.76M | 5.49%3.91M | 121.49%2.52M | 30.49%1.46M |
| Operating expense | 32.04%1.22M | -35.31%3.96M | -49.12%1.4M | -40.79%794.39K | -22.39%839.23K | -1.90%923.14K | 56.85%6.12M | 116.83%2.76M | 32.41%1.34M | 22.95%1.08M |
| Selling and administrative expenses | 30.53%1.2M | -32.50%3.91M | -45.82%1.36M | -39.45%789.55K | -19.94%835.62K | -0.98%922.12K | 47.85%5.79M | 98.28%2.51M | 29.17%1.3M | 15.50%1.04M |
| -Selling and marketing expense | 32.32%691.58K | -11.79%2.28M | -9.45%667.48K | -25.06%531.5K | -2.51%557.18K | -7.56%522.64K | 23.15%2.58M | 12.32%737.1K | 47.14%709.22K | 14.49%571.54K |
| -General and administrative expense | 28.18%512.07K | -49.21%1.63M | -60.97%690.72K | -56.61%258.05K | -41.04%278.44K | 9.20%399.49K | 76.38%3.2M | 191.06%1.77M | 12.74%594.65K | 16.74%472.23K |
| Research and development costs | 1,408.40%15.27K | -68.66%30.44K | 76.78%20.98K | -87.21%4.85K | -90.39%3.61K | -89.69%1.01K | 582.86%97.12K | 65.87%11.87K | 885.23%37.88K | 4,771.73%37.56K |
| Other operating expenses | ---- | -90.12%23.52K | ---- | ---- | ---- | ---- | 1,052.46%238.12K | ---- | ---- | ---- |
| Operating profit | 169.58%560.88K | 15.98%3.06M | 160.85%3M | -36.22%749.9K | -69.52%114.34K | -1,197.99%-806.15K | 13.14%2.64M | -52.68%1.15M | 853.24%1.18M | 58.53%375.13K |
| Net non-operating interest income (expenses) | 20.93%-50.95K | -6.32%-273.44K | -66.93%-88.45K | 21.20%-53.86K | -6.68%-66.69K | 12.13%-64.43K | -617.18%-257.18K | -2,407.62%-52.99K | -499.64%-68.35K | -425.90%-62.51K |
| Non-operating interest expense | -20.93%50.95K | 6.32%273.44K | 66.93%88.45K | -21.20%53.86K | 6.68%66.69K | -12.13%64.43K | 617.18%257.18K | 2,407.62%52.99K | 499.64%68.35K | 425.90%62.51K |
| Other net income (expenses) | -138.33%-44.93K | 83.91%-11.55K | -100.99%-178.94K | 11,241.73%117.21K | 73.30%-71.8K | -164.64%-89.03K | ||||
| Gain on sale of security | -138.33%-44.93K | ---- | ---- | 83.91%-11.55K | -100.99%-178.94K | 11,241.73%117.21K | ---- | ---- | 73.30%-71.8K | -164.64%-89.03K |
| Income before tax | 161.72%465K | 17.02%2.79M | 137.12%2.99M | -33.91%684.48K | -158.72%-131.28K | -451.96%-753.37K | 17.16%2.38M | -47.41%1.26M | 759.63%1.04M | -38.32%223.59K |
| Income tax | 161.72%120.9K | -20.85%609.74K | 40.17%662.79K | -33.91%181.39K | -158.72%-34.79K | -451.96%-195.88K | 4.53%770.35K | -41.88%472.83K | 759.63%274.44K | -38.32%59.25K |
| Earnings from equity interest net of tax | ||||||||||
| Net income | 161.72%344.1K | 35.11%2.18M | 195.30%2.33M | -33.91%503.09K | -158.72%-96.49K | -451.96%-557.49K | 24.34%1.61M | -50.26%787.86K | 759.63%761.18K | -38.32%164.34K |
| Net income continuous operations | 161.72%344.1K | 35.11%2.18M | 195.30%2.33M | -33.91%503.09K | -158.72%-96.49K | -451.96%-557.49K | 24.34%1.61M | -50.26%787.86K | 759.63%761.18K | -38.32%164.34K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 161.72%344.1K | 35.11%2.18M | 195.30%2.33M | -33.91%503.09K | -158.72%-96.49K | -451.96%-557.49K | 24.34%1.61M | -50.26%787.86K | 759.63%761.18K | -38.32%164.34K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 161.72%344.1K | 35.11%2.18M | 195.30%2.33M | -33.91%503.09K | -158.72%-96.49K | -451.96%-557.49K | 24.34%1.61M | -50.26%787.86K | 759.63%761.18K | -38.32%164.34K |
| Diluted earnings per share | 161.11%0.022 | 40.00%0.14 | 200.00%0.15 | -40.00%0.03 | -154.55%-0.006 | -414.29%-0.036 | 150.00%0.1 | 5.57%0.05 | 1,785.77%0.05 | 57.14%0.011 |
| Basic earnings per share | 152.78%0.019 | 44.44%0.13 | 180.00%0.14 | -25.00%0.03 | -160.00%-0.006 | -414.29%-0.036 | 125.00%0.09 | 5.57%0.05 | 1,448.62%0.04 | 42.86%0.01 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
%Chg